| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Service of Endocrinology (L.G., L.L., N.G-P.) Department of Anatomy and Cell Biology (L.G., L.L., N.R., C.A., N.G-P.) Department of Physiology and Biophysics (M.D.P, N.G-P.) Faculty of Medicine University of Sherbrooke Sherbrooke J1H 5N4, Quebec, Canada
In a previous study, we had shown that activation of the AT2 (angiotensin type 2) receptor of angiotensin II (Ang II) induced morphological differentiation of the neuronal cell line NG10815. In the present study, we investigated the nature of the possible intracellular mediators involved in the AT2 effect. We found that stimulation of AT2 receptors in NG10815 cells resulted in time-dependent modulation of tyrosine phosphorylation of a number of cytoplasmic proteins. Stimulation of NG10815 cells with Ang II induced a decrease in GTP-bound p21ras but a sustained increase in the activity of p42mapk and p44mapk as well as neurite outgrowth. Similarly, neurite elongation, increased polymerized tubulin levels, and increased mitogen-activated protein kinase (MAPK) activity were also observed in a stably transfected NG10815 cell line expressing the dominant-negative mutant of p21ras, RasN17. These results support the observation that inhibition of p21ras did not impair the effect of Ang II on its ability to stimulate MAPK activity. While 10 µM of the MEK inhibitor, PD98059, only moderately affected elongation, 50 µM PD98059 completely blocked the Ang II- and the RasN17-mediated induction of neurite outgrowth. These results demonstrate that some of the events associated with the AT2 receptor-induced neuronal morphological differentiation of NG10815 cells not only include inhibition of p21ras but an increase in MAPK activity as well, which is essential for neurite outgrowth.
This article has been cited by other articles:
![]() |
J. Iwanami, M. Mogi, J.-M. Li, K. Tsukuda, L.-J. Min, A. Sakata, T. Fujita, M. Iwai, and M. Horiuchi Deletion of Angiotensin II Type 2 Receptor Attenuates Protective Effects of Bone Marrow Stromal Cell Treatment on Ischemia-Reperfusion Brain Injury in Mice * Supplemental Materials and Methods Stroke, September 1, 2008; 39(9): 2554 - 2559. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kilian, S. Campbell, L. Bilodeau, M.-O. Guimond, C. Roberge, N. Gallo-Payet, and M. D. Payet Angiotensin II Type 2 Receptor Stimulation Increases the Rate of NG108-15 Cell Migration via Actin Depolymerization Endocrinology, June 1, 2008; 149(6): 2923 - 2933. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, X. Zhao, X. Li, K. M. Lerea, and S. C. Olson Angiotensin II type 2 receptor-dependent increases in nitric oxide synthase expression in the pulmonary endothelium is mediated via a G{alpha}i3/Ras/Raf/MAPK pathway Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2185 - C2196. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Plouffe, M.-O. Guimond, H. Beaudry, and N. Gallo-Payet Role of Tyrosine Kinase Receptors in Angiotensin II AT2 Receptor Signaling: Involvement in Neurite Outgrowth and in p42/p44mapk Activation in NG108-15 Cells Endocrinology, October 1, 2006; 147(10): 4646 - 4654. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Beaudry, L. Gendron, M.-O. Guimond, M. D. Payet, and N. Gallo-Payet Involvement of Protein Kinase C{alpha} (PKC{alpha}) in the Early Action of Angiotensin II Type 2 (AT2) Effects on Neurite Outgrowth in NG108-15 Cells: AT2-Receptor Inhibits PKC{alpha} and p21ras Activity Endocrinology, September 1, 2006; 147(9): 4263 - 4272. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mogi, J.-M. Li, J. Iwanami, L.-J. Min, K. Tsukuda, M. Iwai, and M. Horiuchi Angiotensin II Type-2 Receptor Stimulation Prevents Neural Damage by Transcriptional Activation of Methyl Methanesulfonate Sensitive 2 Hypertension, July 1, 2006; 48(1): 141 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D'Amore, M. J. Black, and W. G. Thomas The Angiotensin II Type 2 Receptor Causes Constitutive Growth of Cardiomyocytes and Does Not Antagonize Angiotensin II Type 1 Receptor-Mediated Hypertrophy Hypertension, December 1, 2005; 46(6): 1347 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Otis, S. Campbell, M. D. Payet, and N. Gallo-Payet Angiotensin II Stimulates Protein Synthesis and Inhibits Proliferation in Primary Cultures of Rat Adrenal Glomerulosa Cells Endocrinology, February 1, 2005; 146(2): 633 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bedard, B. Sicotte, J. St-Louis, and M. Brochu Modulation of body fluids and angiotensin II receptors in a rat model of intra-uterine growth restriction J. Physiol., February 1, 2005; 562(3): 937 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Wruck, H. Funke-Kaiser, T. Pufe, H. Kusserow, M. Menk, J. H. Schefe, M. L. Kruse, M. Stoll, and T. Unger Regulation of Transport of the Angiotensin AT2 Receptor by a Novel Membrane-Associated Golgi Protein Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 57 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, K. M. Lerea, J. Li, and S. C. Olson Src Kinase Mediates Angiotensin II-Dependent Increase in Pulmonary Endothelial Nitric Oxide Synthase Am. J. Respir. Cell Mol. Biol., September 1, 2004; 31(3): 365 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Olson, R. Oeckler, X. Li, L. Du, F. Traganos, X. Zhao, and T. Burke-Wolin Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L559 - L568. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Schmitt, G. A. Wayman, N. Nozaki, and T. R. Soderling Calcium Activation of ERK Mediated by Calmodulin Kinase I J. Biol. Chem., June 4, 2004; 279(23): 24064 - 24072. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Bienvenu, K Poirier, H Van Esch, B Hamel, C Moraine, J P Fryns, H H Ropers, C Beldjord, H G Yntema, and J Chelly Rare polymorphic variants of the AGTR2 gene in boys with non-specific mental retardation J. Med. Genet., May 1, 2003; 40(5): 357 - 359. [Full Text] [PDF] |
||||
![]() |
L. Gendron, J.-F. Oligny, M. D. Payet, and N. Gallo-Payet Cyclic AMP-independent Involvement of Rap1/B-Raf in the Angiotensin II AT2 Receptor Signaling Pathway in NG108-15 Cells J. Biol. Chem., January 31, 2003; 278(6): 3606 - 3614. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sarret, L. Gendron, P. Kilian, H. M. K. Nguyen, N. Gallo-Payet, M.-D. Payet, and A. Beaudet Pharmacology and Functional Properties of NTS2 Neurotensin Receptors in Cerebellar Granule Cells J. Biol. Chem., September 20, 2002; 277(39): 36233 - 36243. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Ferguson, D. L.S. Washburn, and K. J. Latchford Hormonal and Neurotransmitter Roles for Angiotensin in the Regulation of Central Autonomic Function Experimental Biology and Medicine, February 1, 2001; 226(2): 85 - 96. [Abstract] [Full Text] |
||||
![]() |
J. L. Hansen, G. Servant, T. J. Baranski, T. Fujita, T. Iiri, and S. P. Sheikh Functional Reconstitution of the Angiotensin II Type 2 Receptor and Gi Activation Circ. Res., October 27, 2000; 87(9): 753 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Elbaz, K. Bedecs, M. Masson, M. Sutren, A. D. Strosberg, and C. Nahmias Functional Trans-inactivation of Insulin Receptor Kinase by Growth-Inhibitory Angiotensin II AT2 Receptor Mol. Endocrinol., June 1, 2000; 14(6): 795 - 804. [Abstract] [Full Text] |
||||
![]() |
A. Chorvatova, L. Gendron, L. Bilodeau, N. Gallo-Payet, and M. D. Payet A Ras-Dependent Chloride Current Activated by Adrenocorticotropin in Rat Adrenal Zona Glomerulosa Cells Endocrinology, February 1, 2000; 141(2): 684 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cote, T. H. Do, L. Laflamme, J.-M. Gallo, and N. Gallo-Payet Activation of the AT2 Receptor of Angiotensin II Induces Neurite Outgrowth and Cell Migration in Microexplant Cultures of the Cerebellum J. Biol. Chem., October 29, 1999; 274(44): 31686 - 31692. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |